Retrospective 20 ICU patients treated with vitamin D in the UAE, and 25 matched controls, showing significantly shorter ICU stay with treatment. Lower proinflammatory cytokines were associated with lower severity markers. Authors also perform a PBMC In Vitro study, with both the clinical and in vitro studies showing vitamin D attenuated major proinflammatory signaling pathways.
Cholecalciferol was used in this study.
Meta analysis shows that late stage treatment with
calcitriol / calcifediol (or
paricalcitol, alfacalcidol, etc.) is more effective than
cholecalciferol:
65% [41‑79%] lower risk vs.
39% [26‑49%] lower risk.
Cholecalciferol requires two hydroxylation steps to become activated - first
in the liver to calcifediol, then in the kidney to calcitriol. Calcitriol,
paricalcitol, and alfacalcidol are active vitamin D analogs that do not
require conversion. This allows them to have more rapid onset of action
compared to cholecalciferol. The time delay for cholecalciferol to increase
serum calcifediol levels can be 2-3 days, and the delay for converting
calcifediol to active calcitriol can be up to 7 days.
, which show efficacy with
p=0.0000024.
This study is excluded in the after exclusion results of meta
analysis:
very late stage study using cholecalciferol instead of calcifediol or calcitriol.
|
ICU time, 35.7% lower, relative time 0.64, p = 0.01, treatment 20, control 25.
|
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Saheb Sharif-Askari et al., 24 Aug 2022, retrospective, USA, peer-reviewed, 10 authors, dosage 50,000IU days 1, 8, 15.
Contact:
rhalwani@sharjah.ac.ae.
Vitamin D modulates systemic inflammation in patients with severe COVID-19
Fatemeh Saheb Sharif-Askari, Shirin Hafezi, Narjes Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Bushra Mdkhana, Balachandar Selvakumar, Mohamad-Hani Temsah, Basema Saddik, Fatme Al Anouti, Rabih Halwani
Life Sciences, doi:10.1016/j.lfs.2022.120909
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
Bhargava, Sotirchos, Eckstein, Ntranos, Gocke et al., High-dose vitamin D supplementation reduces IL-17-producing CD4+ T-cells and effector-memory CD4+ T-cells in multiple sclerosis patients (S38.001, Neurology
Chauss, Freiwald, Mcgregor, Yan, Wang et al., Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells, Nature Immunology,
doi:10.1038/s41590-021-01080-3Chen, Hsieh, Wu, Lin, Chen, Dihydroxyvitamin D3
Chen, Yu, Fu, Wang, Chen et al., Vitamin D3 inhibits lipopolysaccharideinduced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit, Scientific Reports,
doi:10.1038/srep10871Dauletbaev, Herscovitch, Das, Chen, Bernier et al., Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1, British Journal of Pharmacology,
doi:10.1111/bph.13249Gharibi, Babaloo, Hosseini, Abdollahpour-Alitappeh, Hashemi et al., Targeting STAT3 in cancer and autoimmune diseases, European Journal of Pharmacology,
doi:10.1016/j.ejphar.2020.173107Goel, Sharif-Askari, Sharif-Askari, Mdkhana, Mahboub et al., SARS-CoVexpression, Frontiers in Pharmacology
Gupta, Hayek, Chan, Mathews, Melamed, Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US, JAMA Internal Medicine,
doi:10.1001/jamainternmed.2020.3596Kuchipudi, Tellabati, Nelli, White, Perez et al., 18S rRNA is a reliable normalisation gene for real time PCR based on influenza virus infected cells, Virology journal
Li, Tong, Hu, Wang, Lv et al., The relationship between nutritional status and the prognosis of COVID-19: A retrospective analysis of 63 patients, Medicine
Maghbooli, Sahraian, Jamalimoghadamsiahkali, Asadi, Zarei et al., Treatment With 25-Hydroxyvitamin D<sub>3</sub> (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial, Endocrine Practice,
doi:10.1016/j.eprac.2021.09.016Matsuyama, Kubli, Yoshinaga, Pfeffer, Mak, An aberrant STAT pathway is central to COVID-19, Cell Death & Differentiation,
doi:10.1038/s41418-020-00633-7Muhammad, Sharif-Askari, Cui, Hamad, Halwani, SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene, Frontiers in Genetics,
doi:10.3389/fgene.2021.622271Muthian, Raikwar, Rajasingh, Bright, 1,25 dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis, Journal of Neuroscience Research,
doi:10.1002/jnr.20826Rastogi, Bhansali, Khare, Suri, Yaddanapudi et al., Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study), Postgraduate Medical Journal,
doi:10.1136/postgradmedj-2020-139065Sharif-Askari, Sharif-Askari, Goel, Hafezi, Assiri et al., SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway, European Journal of Pharmacology,
doi:10.1016/j.ejphar.2021.174374Zugowski, Lieder, Müller, Gasch, Corvinus et al., STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter,
doi:10.1515/bc.2011.038
